A trial of<unk> /ritonavir is currently being done to study use in COVID-19. So far, studies have not shown significant benefit in time to clinical improvement. Mortality at 28 days is lower but not statistically significant.
Lopinavir
Ritonavir
Remdesivir
Raltegravir
Foscarnet
Baloxavir marboxil
Molnupiravir
Ribavirin